High-performance liquid chromatography - Atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 40, Issue 3, 2006, Pages 707-714

  Zhang, Beibei ^a   Zhang, Zunjian ^a   Tian, Yuan ^a   Xu, Fengguo ^a   Chen, Yun ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF DERMATOLOGY   (China)

Author keywords

HPLC APCI MS; Human plasma; Pharmacokinetics; Zaleplon

Indexed keywords

ACETIC ACID ETHYL ESTER; ESTAZOLAM; METHANOL; SODIUM HYDROXIDE; WATER; ZALEPLON;

ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG IDENTIFICATION; EVAPORATION; EXTRACTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION PROCESS;

ACETAMIDES; ADULT; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FREEZING; HUMANS; HYPNOTICS AND SEDATIVES; INDICATORS AND REAGENTS; MALE; MASS SPECTROMETRY; PYRIMIDINES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TEMPERATURE;

EID: 32444435496     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.06.031     Document Type: Article

References (12)

1. W.E. Heydorn Expert Opin. Investig. Drugs 9 2000 841 858
2. M.G. Terzano, M. Rossi, V. Palomba, A. Smerieri, and L. Parrino Drug Saf. 26 2003 261 282
3. S. Ancoli-Israel, J.K. Walsh, R.M. Mangano, and M. Fujimori Prim. Care. Companion J. Clin. Psychiatry 1 1999 114 120
4. D.R. Drover Clin. Pharmacokinet. 43 2004 227 238
5. A.S. Rosen, P. Fournie, M. Darwish, P. Danjou, and S.M. Troy Biopharm. Drug Dispos. 20 1999 171 175
6. B.G. Lake, S.E. Ball, J. Kao, A.B. Renwick, R.J. Price, and J.A. Scatian Xenobiotica 32 2002 835 847
7. A.B. Renwick, H. Mistry, S.E. Ball, D.G. Walters, J. Kao, and B.G. Lake Xenobiotica 28 1998 337 348
8. K. Kawashima, K. Hosoi, T. Naruke, T. Shiba, M. Kitamura, and T. Watabe Drug Metab. Dispos. 27 1999 422 428
9. C. Horstkotter, D. Schepmann, and G. Blaschke J. Chromatogr. A 1014 2003 71 81
10. C. Giroud, M. Augsburger, A. Menetrey, and P. Margin J. Chromatogr. B 789 2003 131 138
11. F. Feng, J. Jiang, H. Dai, and J. Wu J. Chromatogr. Sci. 41 2003 17 21
12. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.